Bdh2-KO Mouse
Common Name
Bdh2-KO
제품 ID
S-KO-13180
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-69772-Bdh2-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Bdh2-KO Mouse (카탈로그 번호 S-KO-13180)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Bdh2-KO
품종 계통계통 ID
KOCMP-69772-Bdh2-B6J-VB
유전자명
제품 ID
S-KO-13180
유전자 별칭
Dhrs6, 1810026B04Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 3
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000120397
NCBI 전사체 ID
NM_001172055
타겟 영역
Exon 3
유효 영역 크기
~1.1 kb
유전자 연구 개요
Bdh2, short for 3-Hydroxybutyrate dehydrogenase 2, is a member of the short-chain dehydrogenase/reductase family. It serves as a rate-limiting catalyzer in the regulation of intracellular iron metabolism and siderophore biogenesis, and is involved in processes like iron homeostasis, energy metabolism, and apoptosis. It is also associated with pathways such as Keap1/Nrf2/ARE and PI3K/Akt/mTOR [1-4].
In cancer research, Bdh2 shows tumor-suppressing properties. In gastric cancer, its overexpression induces apoptosis and autophagy by promoting Nrf2 ubiquitination, regulating intracellular ROS levels and the PI3K/Akt/mTOR pathway [1]. Similarly, in lung adenocarcinoma, it promotes apoptosis and autophagy via the Akt/mTOR pathway [2]. In hepatocellular carcinoma, it inhibits tumor cell growth, proliferation, and migration, and induces mitochondrial apoptosis while inhibiting autophagy through the unfolded protein response [3]. In leukemia, RAB27B interacts with Bdh2 to inhibit cell proliferation and promote apoptosis [4]. In myelodysplastic syndrome, high Bdh2 expression is related to a poor prognosis, being involved in cell cycle arrest and inhibition of differentiation in malignant cells [6]. In cytogenetically normal acute myeloid leukemia, Bdh2 has an anti-apoptotic role and is a poor prognostic factor [7]. In systemic lupus erythematosus, down-regulation of Bdh2 in CD4+ T cells modulates iron homeostasis, promoting DNA demethylation [5].
In conclusion, Bdh2 plays crucial roles in multiple biological processes, especially in cancer and autoimmune diseases. Studies, including those potentially using gene knockout (KO) or conditional knockout (CKO) mouse models, have revealed its significance in regulating cell apoptosis, autophagy, and iron-related processes, which could potentially provide new therapeutic targets for related diseases.
References:
1. Liu, Jia-Zhou, Hu, Yi-Lin, Feng, Ying, Mao, Qin-Sheng, Xue, Wan-Jiang. 2020. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. In Journal of experimental & clinical cancer research : CR, 39, 123. doi:10.1186/s13046-020-01620-z. https://pubmed.ncbi.nlm.nih.gov/32605589/
2. Nie, Yongli, Mei, Xiong, Cao, Fengjun, Zhu, Xueni. . BDH2 promotes apoptosis and autophagy of lung adenocarcinoma cells via Akt/mTOR pathway. In General physiology and biophysics, 41, 115-122. doi:10.4149/gpb_2022002. https://pubmed.ncbi.nlm.nih.gov/35416174/
3. Liang, Hao, Xiong, Zhiyong, Li, Ruixi, Yao, Zhicheng, Deng, Meihai. 2019. BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy. In Journal of Cancer, 10, 3735-3745. doi:10.7150/jca.32022. https://pubmed.ncbi.nlm.nih.gov/31333791/
4. Meng, Can, Huang, Li, Fu, Xiangjun, Wu, Bin, Lin, Lie. . RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via 3-Hydroxy butyrate dehydrogenase 2 (BDH2). In Bioengineered, 13, 5103-5112. doi:10.1080/21655979.2022.2036903. https://pubmed.ncbi.nlm.nih.gov/35164665/
5. Zhao, Ming, Li, Meng-Ying, Gao, Xiao-Fei, Wu, Hai-Jing, Lu, Qian-Jin. 2017. Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4+ T cells of systemic lupus erythematosus. In Clinical immunology (Orlando, Fla.), 187, 113-121. doi:10.1016/j.clim.2017.11.002. https://pubmed.ncbi.nlm.nih.gov/29113828/
6. Yang, Wen-Chi, Lin, Sheng-Fung, Wang, Shu-Chen, Wu, Chun-Chieh, Wu, Shih-Chi. 2020. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome. In International journal of molecular sciences, 21, . doi:10.3390/ijms21093033. https://pubmed.ncbi.nlm.nih.gov/32344823/
7. Yang, Wen-Chi, Tsai, Wan-Chi, Lin, Pai-Mei, Yu, Wen-Hui, Lin, Sheng-Fung. 2013. Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia. In Journal of biomedical science, 20, 58. doi:10.1186/1423-0127-20-58. https://pubmed.ncbi.nlm.nih.gov/23941109/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
